Results 81 to 90 of about 11,053 (191)

Comparative risk of Guillain–Barré syndrome recombinant and live zoster vaccines: a pharmacovigilance study using VAERS and EudraVigilance database

Immunological Medicine
This study aimed to compare the risk signals of Guillain–Barré syndrome (GBS) associated with recombinant zoster vaccine (RZV) and zoster vaccine live (ZVL) to improve understanding of herpes zoster vaccine safety.
Yinpeng Xu, Fang Li, Li Huang, Dan Mei, Pengqiang Du   +4 more
doaj   +1 more source

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop

Vaccines
The burden of herpes zoster (HZ) is recognized worldwide; however, there is seemingly limited information on incidence and vaccination practices in Southeast Asia (SEA).
Gyneth Lourdes G. Bibera, Peter San Martin, Desiree A. M. van Oorschot, Afif Nurul Hidayati, Deliana Permatasari, Sasheela Sri La Sri Ponnampalavanar, Kughan Govinden, Maria Christina Filomena Batac, Joselito Javier, Terapong Tantawichien, Phatu Boonmahittisut, Trinh Minh Trang, Thanh Tuyen Dang Thi   +12 more
doaj   +1 more source

Management and Prevention of Herpes Zoster: A Canadian Perspective

Canadian Journal of Infectious Diseases and Medical Microbiology, 2010
Varicella-zoster virus reactivation leads to herpes zoster – the main complication of which is postherpetic neuralgia (PHN). Rapid antiviral therapy initiated within 72 h of rash onset has been shown to accelerate rash healing, reduce the duration of ...
Guy Boivin, Roman Jovey, Catherine T Elliott, David M Patrick   +3 more
doaj   +1 more source

Candidate for a live vaccine?

, 2017
Immune dysfunction is a well-known phenomenon in end-stage liver disease (ESLD). The pretransplant period offers a unique window for primary care physicians to optimize the transplant's vaccine protection before antirejection medications are initiated ...
Alan Taege, Justin Ralph Abbatemarco
core   +1 more source

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

Human Vaccines & Immunotherapeutics, 2017
The aim of this study was to compare the public health impact of introducing 2 Herpes Zoster (HZ) vaccines, Zoster Vaccine Live (ZVL) versus a non-live adjuvanted subunit candidate vaccine (HZ/su), in the German population aged 50+ years split into 3 age
Desmond Curran, Desirée Van Oorschot, Lijoy Varghese, Lidia Oostvogels, Tomas Mrkvan, Romulo Colindres, Alfred von Krempelhuber, Anastassia Anastassopoulou   +7 more
doaj   +1 more source

Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature

Frontiers in Immunology, 2018
This narrative review focuses on the herpes zoster (HZ) and its prevention in transplant patients. Varicella zoster virus (VZV) is highly contagious and distributed worldwide in humans.
Lei Wang, Erik A. M. Verschuuren, Coretta C. van Leer-Buter, Stephan J. L. Bakker, Anoek A. E. de Joode, Johanna Westra, Nicolaas A. Bos   +6 more
doaj   +1 more source

Intradermal zoster vaccines: good for the old and the young?

, 2016
In The Lancet Infectious Diseases, Chan R Beals and colleagues report the results of a clinical trial in which varicella-zoster virus specific immunogenicity and adverse events were compared between the Merck live attenuated full dose subcutaneous herpes
Ogunjimi, Benson, Hens, Niel
core   +1 more source

Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review [PDF]

, 2016
Herpes zoster (HZ) is a common, painful and debilitating disease caused by the reactivation of latent varicella-zoster virus in ganglia. This clinical event occurs more frequently in the elderly and those who are immunocompromised.
TRUCCHI, CECILIA, ALICINO, CRISTIANO, Cecilia Trucchi, PAGANINO, CHIARA, Andrea Orsi, Giancarlo Icardi, ANSALDI, FILIPPO, ICARDI, GIANCARLO, ORSI, ANDREA, Filippo Ansaldi, Cristiano Alicino, Chiara Paganino   +11 more
core   +1 more source

Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data

Современная ревматология
Patients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population.
N. V. Muravyova, B. S. Belov
doaj   +1 more source

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions

Vaccines
Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein E (gE). Here,
Chanyeong Lee, Minjee Kim, Jungmin Chun, Sehyun Kim, Doyoung Yoon, Hyeondong Lee, Heewon Bang, Hee-Jung Lee, Hosun Park, Young Bong Kim   +9 more
doaj   +1 more source